Patient Death Obscures Efficacy Success For Sophiris’ Intratumoral Prostate Cancer Therapy

The bad outweighed the good for Sophiris on a day in which it unveiled promising Phase IIb data for topsalysin...

More From BioPortfolio on "Patient Death Obscures Efficacy Success For Sophiris’ Intratumoral Prostate Cancer Therapy"